Overview of PT-141 for Research
PT-141, also called bremelanotide, is a synthetic cyclic heptapeptide developed as a research probe for the melanocortin receptor system. Its amino acid sequence is Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH, a lactam-bridged analog of the endogenous hormone α‑melanocyte‑stimulating hormone (α‑MSH). In controlled laboratory environments, PT-141 is employed to investigate the signaling characteristics of melanocortin receptors, particularly MC3R and MC4R. Published pharmacological profiling indicates that PT-141 interacts with these receptors at nanomolar concentrations, making it a useful tool for both in vitro binding assays and animal model investigations. All products described, including PT-141, are manufactured exclusively for laboratory research purposes; they are not intended for human or veterinary application, nor for any diagnostic, therapeutic, or clinical procedure.
Importance of GMP in Peptide Manufacturing
Good Manufacturing Practice (GMP) constitutes a set of globally recognized quality assurance guidelines that govern every facet of production, from facility design to final product release. In peptide manufacturing, adherence to GMP principles is critical because even minor variations in impurity profiles, residual solvents, or stereochemical fidelity can alter experimental outcomes. Research laboratories and pharmaceutical companies depend on peptide suppliers who deliver consistent purity and batch-to-batch reproducibility; only through rigorous process controls and independent audits can a manufacturer provide that reliability. Working with a qualified PT-141 GMP manufacturer therefore minimizes variables that could confound receptor pharmacology studies, animal behavioral experiments, or structure‑activity relationship campaigns.
What GMP Certification Ensures
- Full traceability of every raw material, intermediate, and finished lot, supported by certificates of analysis and a documented chain of custody.
- Validated analytical methods for identity, purity, and impurity profiling, ensuring that every batch meets predefined specifications before release.
- Comprehensive batch records that capture equipment cleaning logs, in‑process controls, and personnel training, enabling rapid review by regulatory bodies or research partners.
These elements align with the expectations of international guidance documents such as the ICH Q7 standard for active pharmaceutical ingredients, providing confidence that the peptide will perform predictably in downstream laboratory assays.
Our PT-141 GMP Manufacturing Process
As a specialized PT-141 GMP manufacturer, we have engineered a production workflow that integrates solid‑phase peptide synthesis (SPPS) with orthogonal purification and multi‑tiered quality control. Every step is performed in a controlled, dedicated facility under a quality management system that mirrors the principles of ICH Q7. This process delivers research‑grade PT-141 with a consistently verified purity exceeding 98%.
Raw Material Sourcing
All Fmoc‑protected amino acids, resins, coupling reagents, and solvents are procured from pre‑qualified suppliers who furnish detailed certificates of analysis with each shipment. Upon receipt, raw materials undergo identity testing, assay, and checks for residual solvents or heavy metals. Only materials that meet our internal specifications are released for production. Lot‑specific segregation and a computerized inventory system eliminate the risk of cross‑contamination between different peptide campaigns.
Synthesis and Purification
PT-141 is assembled on an automated peptide synthesizer using standard Fmoc chemistry. After stepwise chain elongation, the peptide‑resin is treated with a cleavage cocktail containing trifluoroacetic acid and scavengers to remove side‑chain protecting groups and liberate the cyclic peptide. The crude product is then purified by preparative high‑performance liquid chromatography (HPLC) on a C18 column, employing a water‑acetonitrile gradient with 0.1% TFA. This gradient elution method separates the target peptide from deletion sequences, diastereomers, and other impurities, yielding a single peak in the final analytical chromatogram.
Quality Control and Testing
Every lot of research‑grade PT-141 undergoes a rigorous release panel:
- Reinheitsbewertung: Analytical HPLC coupled with electrospray ionization mass spectrometry (ESI‑MS) confirms purity >98% and the correct molecular ion.
- Identitätsprüfung: Amino acid analysis and MS/MS sequencing corroborate the heptapeptide sequence and cyclic structure.
- Endotoxin monitoring: Endotoxin levels are quantified per USP general chapter <85> guidelines to ensure compatibility with sensitive cell‑based assays.
- Residual solvent analysis: Headspace GC‑MS confirms that residual solvents are below limits derived from ICH Q3C recommendations.
- Stability evaluation: Real‑time and accelerated stability studies under recommended storage conditions (lyophilized, ‑20°C, desiccated) are performed to define shelf‑life and guide proper laboratory handling.
Applications of PT-141 in Laboratory Research
Because of its selectivity for central melanocortin receptors, PT-141 is a versatile molecular probe for academic and industrial research programs that explore neuropeptide signaling, receptor pharmacology, and behavioral neuroscience. All uses remain firmly within the domain of laboratory research, with no clinical or in‑human application whatsoever.
In Vitro Studies
Cell‑based assays allow researchers to characterize the functional properties of PT-141 at recombinant melanocortin receptors. Common experimental designs include:
- cAMP accumulation assays in HEK‑293 or CHO cells stably expressing MC3R, MC4R, or MC5R, using luminescence or fluorescence readouts.
- Radioligand competition binding with 125I‑labeled NDP‑α‑MSH to determine affinity constants and receptor subtype selectivity profiles.
- Functional selectivity profiling that measures activation of downstream effectors such as β‑arrestin recruitment or ERK phosphorylation, helping to delineate biased signaling pathways.
Animal Model Investigations
In rodent models, PT-141 is administered via systemic or central routes to study melanocortin‑mediated behaviors. Experimental endpoints include motivated behaviors, ingestive responses, and social interaction paradigms. By conducting concentration‑ or amount‑response studies, researchers map the relationship between peptide exposure and behavioral change without implying any therapeutic benefit. In parallel, pharmacokinetic sampling (plasma and brain tissue) followed by LC‑MS/MS analysis provides data on peptide stability and tissue distribution, which is essential for interpreting receptor occupancy relationships.
Partnering with a Reliable PT-141 GMP Manufacturer
For laboratories that need custom modifications, gram‑scale quantities, or reliable global delivery, collaboration with an experienced PT-141 GMP manufacturer streamlines the supply chain and preserves experimental integrity. Our manufacturing model is built to support long‑term research partnerships through flexible synthesis options and robust logistical support.
Custom Synthesis Capabilities
Beyond catalog PT-141, we offer bespoke synthesis tailored to specific research objectives:
- Labeled variants: Conjugation with fluorophores (e.g., FITC, Cy5), biotin, or stable isotopes (13C, 15N) for imaging and quantitative proteomics.
- Scale‑up: Seamless transition from milligram synthesis for feasibility studies to multi‑gram production for extended in vivo protocols, with identical quality attributes maintained at every scale.
- Confidential collaboration: Custom peptide sequences and modifications are protected under non‑disclosure agreements, safeguarding proprietary research directions.
Global Logistics and Compliance
We provide temperature‑controlled international shipping with validated cold‑chain packaging and real‑time temperature loggers to preserve peptide integrity during transit. Our regulatory affairs team assists with export permits, customs documentation, and classification under applicable chemical control frameworks such as EU REACH or the U.S. Toxic Substances Control Act. Each shipment includes a detailed certificate of analysis, HPLC and MS traces, and a safety data sheet, enabling seamless import into institutional or corporate research facilities.
Hinweis: Nur für Forschungszwecke: All products supplied, including PT-141, are intended exclusively for in vitro laboratory research use by qualified professionals. They are not designed, manufactured, or authorized for human or veterinary administration, nor for any diagnostic, therapeutic, or clinical procedure. Handling should be performed in accordance with the provided safety data sheet and institutional guidelines.
Nur für Forschungszwecke. Nicht zur Anwendung am Menschen oder bei Tieren bestimmt.
